Hinge Health Inc. (NYSE:HNGE - Get Free Report) was the recipient of unusually large options trading activity on Monday. Traders bought 6,399 call options on the stock. This represents an increase of approximately 465% compared to the average daily volume of 1,132 call options.
Wall Street Analysts Forecast Growth
Several research analysts recently weighed in on the company. Needham & Company LLC started coverage on Hinge Health in a research note on Monday, June 16th. They set a "buy" rating and a $47.00 target price for the company. KeyCorp started coverage on Hinge Health in a research note on Monday, June 16th. They set an "overweight" rating and a $45.00 price objective for the company. Piper Sandler assumed coverage on Hinge Health in a research report on Monday, June 16th. They set an "overweight" rating and a $41.00 target price on the stock. William Blair assumed coverage on Hinge Health in a report on Monday, June 16th. They set an "outperform" rating for the company. Finally, Bank of America assumed coverage on Hinge Health in a research note on Monday, June 16th. They issued a "buy" rating and a $42.00 price target on the stock. One investment analyst has rated the stock with a hold rating and thirteen have issued a buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $46.00.
Check Out Our Latest Stock Report on HNGE
Hinge Health Trading Up 5.5%
Shares of Hinge Health stock traded up $2.33 during trading on Monday, reaching $44.40. The company's stock had a trading volume of 691,888 shares, compared to its average volume of 809,076. Hinge Health has a one year low of $33.42 and a one year high of $45.98.
About Hinge Health
(
Get Free Report)
Our vision is to build a new health system that transforms outcomes, experience and costs by using technology to scale and automate the delivery of care. Hinge Health leverages software, including AI, to largely automate care for joint and muscle health, delivering an outstanding member experience, improved member outcomes, and cost reductions for our clients.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Hinge Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hinge Health wasn't on the list.
While Hinge Health currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.